How Emergent BioSolutions Earned Profits But Delivered Disappointing Vaccine Returns
After awarding Emergent the no-bid contract, the Trump administration reverted to traditional contracting rules and sought competitive proposals for additional bottling and packaging, known in the industry as fill-finish work, the documents show. Ology Bioservices, based in Alachua, Fla., agreed to provide essentially the same services as Emergent’s Camden and Rockville plants for three-quarters to…